Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.67 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.66 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.62 |
| ▸ | CASP2 | P42575 | 1/20 | 0.62 |
| ▸ | NAAA | Q02083 | 1/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.54 |
| ▸ | SELP | P16109 | 1/20 | 0.54 |
| ▸ | CNR1 | P21554 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14686016 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL16852243 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL10031646 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL1984951 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL1813350 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL3914543 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL23673836 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL3910766 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL7777076 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL1813706 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1010717-B1 | Oil-in-water emulsion of organopolysiloxane and method for the preparation thereof | SHINETSU CHEMICAL CO (JP) | 2004-09-22 | — | — | EP | claimed |
| US-6316545-B1 | USEFUL AS AN ADJUVANT INGREDIENT IN TOILETRY PREPARATIONS FOR HAIR-CARE TREATMENT, POLISHING AGENTS, MOLD-RELEASE AGENTS, FABRIC-FINISHING AGENTS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-11-13 | — | — | US | claimed |
| EP-1010717-A2 | Oil-in-water emulsion of organopolysiloxane and method for the preparation thereof | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2000-06-21 | — | — | EP | claimed |
| CN-111936462-B | Adhesion-promoting stabilizer and solvent composition for electronic device manufacture using the same | 株式会社大赛璐 | 2023-11-03 | — | — | CN | disclosed |
| US-20230265430-A1 | RNAi Agents for Inhibiting Expression of DUX4, Compositions Thereof, And Methods of Use | SIXTH STREETLENDING PARTNERS, AS THE ADMINISTRATIVE AGENT | 2023-08-24 | — | — | US | disclosed |
| WO-2021149502-A1 | COMPOSITION AND METHOD FOR PRODUCING SAME | 株式会社ダイセル | 2021-07-29 | — | — | WO | disclosed |
| EP-1010717-B1 | Oil-in-water emulsion of organopolysiloxane and method for the preparation thereof | SHINETSU CHEMICAL CO (JP) | 2004-09-22 | — | — | EP | disclosed |
| EP-0963385-B1 | CATALYST COMPOSITION | BASELL POLYOLEFINE GMBH (DE) | 2004-06-16 | — | — | EP | disclosed |
| US-6316545-B1 | USEFUL AS AN ADJUVANT INGREDIENT IN TOILETRY PREPARATIONS FOR HAIR-CARE TREATMENT, POLISHING AGENTS, MOLD-RELEASE AGENTS, FABRIC-FINISHING AGENTS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-11-13 | — | — | US | disclosed |
| EP-1010717-A2 | Oil-in-water emulsion of organopolysiloxane and method for the preparation thereof | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2000-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265430-A1 | RNAi Agents for Inhibiting Expression of DUX4, Compositions Thereof, And Methods of Use | ZFX, DDX39B, DDX21 | FAAH 3378/4885SLC6A5 4669/4885DNM1 1104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.